GRPR and glioblastoma: To address this challenge, 68Ga-NOTA-BBN-IR-800CW, which targets the gastrin-releasing peptide receptor (GRPR) using a 14 amino acid sequence peptide, was derived from a PET radiotracer and applied for glioblastoma (Figure 1c) [20].